Emerging player in the minimally invasive outpatient pain
Differentiated market, focusing on the relatively infant "Midline" Spine
Surgery sector
Approved
Commercial
Riding industry tailwinds of aging demographics, transition to
Reimbursed outpatient care settings, and strong focus on faster recovery
Derisked and risk-reduction
Proposed raise: $20-25mm Strong track record with support from the LINK Group in terms
of industry and technological expertise, intellectual and
financial capital, commercial experience, and etc.
Investment proceeds will be used to:
• Build a robust commercial sales and marketing infrastructure
Deutsche Bank key contacts:
▪ Expand geographically, specifically in the sun-belt states of Florida,
Georgia, Texas, Arizona and California
Seth Damergy Benjamin Bible
▪ Hybrid distribution strategy to include direct representation and Managing Director Vice President
partnership with independent agents that focus upon novelty Global Head of Medical Technology Healthcare, Medical Technology
▪ Launch, commercialize, and tightly integrate unique and low-cost
navigation system for maximized pull through of implant platform
• Continue to innovate highly-engineered novelty minimally-invasive
products
LINKSPINE 8
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0092346
CONFIDENTIAL SDNY_GM_00238530
EFTA01388661